Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Nikile Ntsababa (Registrar)

The nomination process for the election of two representatives to serve on the UFS Council was finalised on Tuesday, 17 September 2019 – the closing date for nominations.
 
Here are the names of the nominees (listed alphabetically):
 
Representative from the Qwaqwa Campus:
None
 
Other representative:
Mr Christo Dippenaar
Dr Pieter du Toit
Mr Lefa Mabaso
Dr Walter Matli
Mr Zama Sigwebela
 
Please note that no nominations were received for representatives from the Qwaqwa Campus.  Since this scenario is not legislated in the Statute, Institutional Rules, and Convocation Constitution, the Registrar will, after consultation with the President of the Convocation, open another round of nominations for Qwaqwa representatives to Council (with the closing date 8 October 2019) to ensure that the campus is also represented on Council.
 
Convocation and Alumni members from the Qwaqwa Campus are therefore given a second opportunity to nominate one representative from among their members for the Qwaqwa Campus.  All nominations must reach the office of the Registrar no later than 16:30 on Wednesday, 9 October 2019.
 
Every nomination form  shall be signed by four (4) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature as well as an abridged CV and a motivation of more or less 200 words.
 
Nominations are to be submitted to:  email: registrar@ufs.ac.za or delivered by hand to Nikile Ntsababa, Main Building, Room 51, Bloemfontein Campus.
 
Kindly take note that late or incomplete nominations will not be accepted or considered.
 
Further information regarding the election process will follow in due course.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept